Men with erectile dysfunction (ED) that is unresponsive to available oral pharmacotherapy with PDE5 inhibitors represent a significant subgroup of patients with the disorder. Such patients might in the near future benefit from regenerative medicine options that restore tissue integrity and signalling in penis-projecting neurons, penile smooth muscle cells and endothelial cells. In this comprehensive Review, the authors discuss the current cutting-edge research in regenerative medicine for ED and consider the therapeutic potential of these techniques for the future.
- Lukman Hakim
- Frank Van der Aa
- Maarten Albersen